Schedule 13G ownership disclosure

UROGEN PHARMA LTD

Security class unavailable · CUSIP: M96088105

Event date: 2023-12-19

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-130500
Form type
SC 13G
Filer
RA CAPITAL MANAGEMENT, L.P.
CIK
CIK 1346824
Filed
Dec 29, 2023
Reporting period
Dec 19, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub